Body surface mapping improves early diagnosis of acute myocardial infarction in patients with chest pain and left bundle branch block
- 1Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK
- 2University of Ulster, Jordanstown, Northern Ireland, UK
- Correspondence to:
Professor AA Jennifer Adgey, Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor Road, Belfast, Northern Ireland, UK, BT12 6BA;
- Accepted 17 April 2003
Objective: To test prospectively depolarisation and repolarisation body surface maps (BSMs) for mirror image reversal, which is less susceptible to artefact, in patients with acute ischaemic-type chest pain, and to compare these BSM criteria with previously published 12 lead ECG criteria
Methods: An 80 lead portable BSM system was used to map patients presenting with acute ischaemic-type chest pain and a 12 lead ECG with left bundle branch block (LBBB). Acute myocardial infarction (AMI) was defined by serial cardiac enzymes. Each 12 lead ECG was assessed by the criteria of Sgarbossa et al and Hands et al for diagnosis of AMI. Depolarisation and repolarisation BSMs were assessed for loss of mirror image reversal of QRS with ST-T isointegral map patterns and a change in vector angle from QRS to ST-T outside 180±15°—findings typically seen in LBBB with AMI.
Results: Of 56 patients with chest pain and LBBB, 18 had enzymatically confirmed AMI. Patients with loss of BSM image reversal were significantly more likely to have AMI (odds ratio 4.9, 95% confidence interval 1.5 to 16.4, p = 0.007). Loss of BSM image reversal was significantly more sensitive (67%) for AMI than either 12 lead ECG method (17%, 33%) albeit with some loss in specificity (BSM 71%, 12 lead ECG 87%, 97%). Patients with AMI compared with those without AMI had a greater mean change in vector angle outside the normal range (180±15°), particularly between QRS isointegral and ST60 isopotential (the potential 60 ms after the J point at each electrode site) BSMs (19° v 9°, p = 0.038). Loss of image reversal and QRS-ST60 vector change outside 180±15° had 61% sensitivity and 82% specificity for AMI (odds ratio 7.0, 95% confidence interval 2.0 to 24.4, p = 0.001).
Conclusions: BSM compared with the 12 lead ECG improved the early diagnosis of AMI in the presence of LBBB.
- AMI, acute myocardial infarction
- BSM, body surface map
- GUSTO-1, global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries
- LBBB, left bundle branch block
- MI, myocardial infarction
In patients with acute ischaemic-type chest pain, the 12 lead ECG has limited usefulness for early diagnosis of acute myocardial infarction (AMI) in the presence of left bundle branch block (LBBB).1 Patients with AMI and LBBB have a worse prognosis than those without LBBB2 but are less likely to receive a fibrinolytic agent, which has been shown to reduce mortality, because of difficulties in early diagnosis.3,4 Improved early diagnosis may optimise use of fibrinolysis, thus further reducing mortality. Although various ECG criteria have been proposed for diagnosis of AMI with LBBB,5–8 none has been widely accepted.
Body surface maps (BSMs) have enabled identification of prior myocardial infarction (MI) in those with LBBB9–11 but its use in AMI has been limited by technical difficulties. With advances in bioengineering and a novel self adhesive electrode harness, BSMs are now recorded in a similar time as that taken to record a 12 lead ECG. Early work in LBBB without AMI found that the cardiac vector (which runs from minimum to maximum value) typically changed direction by 180±15° when comparing depolarisation with repolarisation maps, whereas in LBBB with AMI, the change in vector direction was outside these limits.12 Vector measurement, however, can be susceptible to lead artefact. The objective of this study was to test prospectively depolarisation and repolarisation BSMs for mirror image reversal, which is less susceptible to artefact, in patients with acute ischaemic-type chest pain, and to compare these BSM criteria with previously published 12 lead ECG criteria.5,6 In an earlier study, preliminary work has shown this method to improve diagnostic sensitivity for AMI in patients with acute chest pain with LBBB, while maintaining acceptable specificity in both these patients and those with chronic LBBB without ischaemic symptoms.13
Consecutive patients admitted to an acute medical cardiology unit in a tertiary hospital between September 1995 and November 1999 were mapped. Patients were included if they had chest pain suggestive of AMI with LBBB on the initial ECG and a BSM obtained within 12 hours of the onset of pain, before or within 15 minutes of starting fibrinolytic treatment (if given) and within 15 minutes of the index 12 lead ECG. Baseline characteristics were defined as: hypercholesterolaemia (fasting total cholesterol⩾ 5.2 mmol/l (⩾ 202.8 mg/dl) or current treatment with lipid lowering treatment), hypertension (serial blood pressure readings during admission ⩾ 160/90 mm Hg or current with antihypertensive treatment), diabetes mellitus (fasting plasma glucose > 7.8 mmol/l or a previous diagnosis requiring dietary modification, oral medication or insulin), and familial history of ischaemic heart disease (first degree relative with age of onset ⩽ 55 years for men or ⩽ 65 years for women). All patients had serum creatine kinase measured on admission and on the following day. AMI was defined as creatine kinase > 2 times the upper limit of normal (upper limit 140 IU/l) and/or increased creatine kinase MB fraction (> 25 IU/l or ⩾ 7% of the total creatine kinase).
12 lead ECG analysis
LBBB was considered to be present if all of the following criteria were met: QRS duration ⩾ 120 ms; small or absent initial R waves in V1 and V2 followed by deep S waves; broad, notched R waves in leads V5 and V6 and usually I and aVL; and absent septal Q waves in left sided leads.14 The 12 lead ECGs were analysed by two methods. The first method (Sgarbossa et al5) allocated scores for three 12 lead ECG features: ST elevation ⩾ 1 mm in any lead concordant with the QRS complex; ST depression ⩾ 1 mm in leads V1, V2, or V3; and ST elevation ⩾ 5 mm in any lead, discordant with the QRS complex. The second method (Hands et al6) required any one of the following for diagnosis of acute or prior MI: Q waves in ⩾ 2 of leads I, aVL, V5, or V6; R wave regression from V1 to V4; notching of the upstroke of the S wave in ⩾ 2 of leads V3, V4, or V5; or primary ST-T wave changes in ⩾ 2 adjacent leads.
The BSM system used has previously been described.15,16 Briefly, the system consists of an anterior and posterior electrode harness, a recording unit, and a personal computer. The flexible plastic harness contains 64 anterior electrodes (including proximal limb electrodes) and 16 posterior electrodes. Silver–silver chloride electrodes are screen printed on to the harness, with self adhesive hydrogel pads allowing good skin contact. The electrodes are arranged in 11 vertical strips, referenced to anatomical markings: anterior (from right to left)—right mid clavicular line, right parasternal line (V1 line), left parasternal line (V2 line), left medial-clavicular line (V3 line), left mid clavicular line (V4 line), left anterior axillary line (V5 line), and left mid axillary line (V6 line); and posterior (from right to left)—right mid axillary line, right posterior axillary line, left paraspinal line, and left posterior axillary line. BSMs are recorded over five seconds at a sampling rate of 1 kHz simultaneously and bandwidth of 0.05–100 Hz. The digital data are stored on a 512 kb memory card and downloaded on to a personal computer.
Data processing and display
Data were processed using custom software. Noise was removed using subtraction filtering. Leads of poor quality were manually identified and substituted with values obtained by linear grid interpolation. To avoid excessive reliance on interpolation, a recording was deemed unusable if there were more than six poor quality channels, orthogonally adjacent poor quality channels (that is, horizontally or vertically but not diagonally adjacent), or any posterior poor quality channels. The QRST complex providing the best overall signal quality was selected. Markers were placed at QRS onset, J point, and T wave offset (but before any U wave). Maps were displayed in colour contour format with green equal to zero; positive values were given linear allocation from green towards red and negative values were given linear allocation from green towards blue. The most positive value was termed the “maximum” and the area surrounding it (⩾ 50% of the value of the maximum) was termed the “maxima”. The most negative value was termed the “minimum” and the area surrounding it (⩾ 50% of the value of the minimum) was termed the “minima”. The cardiac vector was drawn from minimum to maximum. Colours were displayed on a flat representation of the thorax, depicted as if “unwrapped” from a vertical split at the right axilla (fig 1).
QRS and ST-T isointegral maps (that is, the area under the QRS and ST-T curves, respectively, at each of the electrode sites) were displayed in addition to ST0 and ST60 isopotential maps (the potential 0 ms and 60 ms, respectively, after the J point at each electrode site). The normal QRS isointegral map of a patient with LBBB but without AMI (fig 1A) typically shows maximum potential located over the left anterior chest, left axilla, or left posterior chest, with minimum potential located on the upper midanterior chest. The normal ST-T isointegral map from a patient with LBBB is typically a mirror image of the QRS map—that is, maximum potential on the upper or midanterior chest and minimum potential located over the left anterior chest, left axilla, or left posterior chest. Thus, the cardiac vector (drawn from minimum to maximum) typically changes direction by approximately 180°.
For this study, mirror image reversal was defined to be present if the central point of the maxima on the QRS isointegral map concurred (±1 electrode position horizontally, vertically, or diagonally) with the central point of the minima on a repolarisation map (for example, ST-T isointegral map) and the central point of the minima on the QRS isointegral map concurred (±1 electrode position) with the central point of the maxima on the ST-T isointegral map. Loss of image reversal was considered to be suggestive of AMI (fig 1B). A normal change in vector angle (for LBBB without AMI) on comparing depolarisation (QRS isointegral) with repolarisation maps (ST-T isointegral, ST0 isopotential, or ST60 isopotential) was defined as 180±15°. A change in direction outside these limits was considered to be suggestive of AMI.
Baseline categorical variables were analysed by χ2 and continuous clinical variables by analysis of variance or Mann-Whitney U test as appropriate. A probability value of p < 0.05 was taken as significant. All patients were required to give informed consent, using a local ethics committee approved patient information sheet and consent form.
Fifty six patients with acute chest pain were identified who met enrolment criteria, 18 with AMI as diagnosed by cardiac enzymes (of whom seven received a fibrinolytic agent) and 38 without significant enzyme rise (of whom three received a fibrinolytic agent based on initial clinical suspicion of AMI). Table 1 shows baseline demographics.
12 lead ECG analysis
Sgarbossa et al5 criteria correctly identified 6 of 18 patients with enzymatically confirmed AMI and excluded AMI in 37 of 38 patients (sensitivity 33%, specificity 97%, positive predictive value 86%, and negative predictive value 76% for AMI). Hands et al6 criteria correctly identified only 3 of 18 patients with enzymatically confirmed AMI and excluded AMI in 33 of 38 patients (sensitivity 17%, specificity 87%, positive predictive value 38%, and negative predictive value 69% for AMI).
Image reversal analysis (whereby loss of mirror image reversal comparing QRS and ST-T isointegral maps was suggestive of AMI) correctly identified AMI in 12 of 18 patients and excluded AMI in 27 of 38 patients (67% sensitivity, 71% specificity, 52% positive predictive value, and 82% negative predictive value for AMI) (table 2). Patients with loss of image reversal were significantly more likely to have AMI (odds ratio (OR) 4.9, 95% confidence interval (CI) 1.5 to 16.4; p = 0.007). BSM image reversal analysis was significantly more sensitive for AMI than either 12 lead ECG method (p < 0.05 v Sgarbossa et al5; p < 0.001 v Hands et al6) with some loss in specificity (Sgarbossa et al5 p < 0.001; Hands et al6 p < 0.001). Comparing the QRS isointegral with each of the three repolarisation BSMs (ST-T isointegral, ST0 isopotential or ST60 isopotential) and taking loss of mirror image reversal in at least two of three maps as suggestive of AMI, sensitivity was 56% and specificity 74%.
Change in vector direction from QRS isointegral to each of the three repolarisation BSMs (ST-T isointegral, ST0 or ST60 isopotential) showed that those with AMI compared with those without AMI had a greater mean change in vector angle outside the normal range (180±15°), particularly for the QRS-ST60 comparison (19° v 9°, p = 0.038).
Loss of image reversal and QRS-ST60 vector change outside 180±15° correctly identified AMI in 11 of 18 patients and excluded AMI in 31 of 38 patients (61% sensitivity, 82% specificity, 61% positive predictive value, and 82% negative predictive value for AMI). Patients with loss of image reversal and QRS-ST60 vector change outside 180±15° were significantly more likely to have AMI (OR 7.0, 95% CI 2.0 to 24.4; p = 0.001).
The diagnosis of AMI in the presence of LBBB is of key importance, as the high mortality associated with this condition can be reduced by fibrinolytic treatment.4 Blind administration of a fibrinolytic agent, however, to all patients with chest pain suggestive of AMI and LBBB on the 12 lead ECG is not an optimal practice because of the risk of severe haemorrhage, especially intracranial bleeding, estimated to occur in approximately 1% of patients.17
In the past, to diagnose AMI in the setting of LBBB, several approaches to 12 lead ECG analysis have been proposed but the results have been disappointing (table 3). Sgarbossa et al5 analysed 131 patients with LBBB and AMI enrolled as part of the GUSTO-1 (global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries) trial and reported criteria with 36% sensitivity, 96% specificity, 88% positive predictive, and 61% negative predictive values for AMI. However, one of the components, ST elevation ⩾ 5 mm in any lead discordant with the QRS complex of that lead, has been found by Madias et al18 to occur in LBBB without AMI. Hands et al6 tested 11 ECG criteria for diagnosis of acute and/or prior MI in 35 patients with LBBB (24 having AMI or prior MI). Four of these criteria were found to be highly specific (91–100%) and predictive (86–100%) but to have poor sensitivity 21–29%. Eriksson et al7 and Shlipak et al1 also reported poor sensitivity. Wackers8 found that ST elevation had a sensitivity of 54%, abnormal Q waves 31%, and notching of the upstroke of the S wave in V3 or V4 27%. He also found serial ECG changes to be most sensitive for diagnosis of AMI in the presence of LBBB (sensitivity 67%), but time to treatment is crucial in managing AMI.
Almost all work performed on BSMs in patients with ischaemic heart disease with LBBB has been recognising prior MI.9–11 Musso et al9 were not able to identify prior MI in patients with LBBB by visually inspecting BSMs but differences in potential magnitudes were observed, whereby lower values were seen in patients with prior MI than in those with uncomplicated LBBB. Suzuki et al10 recorded QRST isointegral maps during sinus rhythm and right ventricular pacing in 62 patients with previous MI and 26 patients without MI. Abnormalities over the anterior left chest with old anterior MI and over the lower chest with prior inferior MI were seen. For diagnosing prior MI they found 84% sensitivity and 81% specificity if the sum of the QRST isointegrals below the normal range exceeded 100 mV.ms. Nishiyama et al11 compared QRST isointegral BSMs, 12 lead ECGs, and vectorcardiograms in paced rhythm in controls and in patients with prior inferior MI and found that, of the three methods, BSM had superior correlation with the severity of left ventricular wall motion abnormalities.
During mapping of patients with AMI with LBBB, it has been found that the injury currents generated by acutely infarcting tissue disturb the patterns of repolarisation typically seen in patients with LBBB uncomplicated by AMI.12 Thus, AMI may result in loss of the mirror image reversal of the positions of maxima and minima normally seen between the depolarisation (QRS) and repolarisation (ST-T) maps. Similarly, AMI may result in a change in the cardiac vector (running from minimum to maximum) outside the normal 180±15° typically seen between QRS and ST-T maps. However, measurement of the vector angle may be susceptible to even minor degrees of artefact, particularly in posterior electrodes, leading to an erroneous change in vector angle. Furthermore, eccentric loci of maximum or minimum positions within maxima and minima areas, respectively, may lead to apparently abnormal vector changes despite mirror image reversal between QRS and ST-T isointegral maps. Thus, quantitative assessment of mirror image reversal in this study proved particularly useful.
Analysis of patient subgroups and other cardiac conditions such as those with prior MI, left axis deviation, and left ventricular hypertrophy was not possible, as numbers would have been too small to draw meaningful conclusions.
The results obtained using BSM are encouraging. Sensitivity for AMI is significantly superior to that of 12 lead ECG algorithms. Although specificity is reduced, it is within acceptable limits to allow this method to be clinically useful. We did not use troponin I or T as a cardiac marker, as these were not routinely assessed when the study began. It is likely that troponin measurement would have detected more cases of AMI, potentially reducing the number of false positives identified by BSM.
The importance of sensitivity over specificity in patients with LBBB and AMI should be recognised. AMI has been reported to be present in 30% of patients with LBBB presenting with acute cardiac symptoms,1 and fibrinolytic treatment in such patients has been shown to reduce mortality from at least 23.6% to 18.7% (all bundle branch blocks at 35 days).17 However, fibrinolytic treatment is associated with a 1% risk of haemorrhagic stroke.17 If we extrapolate our results to a population of 1000 patients with LBBB with chest pain of whom 30% have AMI, BSM image reversal compared with Sgarbossa et al5 12 lead ECG criteria would enable correct identification of an additional 102 patients, but would inappropriately diagnose AMI in an additional 182 patients. Administration of a fibrinolytic agent guided by BSM compared with 12 lead ECG criteria would thus potentially save at least five additional lives, at a cost of 1.4–2.8 haemorrhagic strokes (depending on the lytic agent).
The current cost per BSM recording is approximately £30 (approximately £45). Thus, in a population of 1000 patients with LBBB, the cost per correct early diagnosis of AMI (total n = 201) would be approximately £149 (approximately £230). Given a total of eight lives saved (4.9% mortality reduction among 201 AMIs with LBBB minus a 50% mortality rate17 among 2.8 haemorrhagic strokes), the cost per life saved by BSM guided fibrinolytic treatment would be approximately £3750 (approximately £5700).
While our study size was modest and extrapolated results should be interpreted with caution, nevertheless, our results suggest that adoption of BSM will lead to an overall improvement in treatment of AMI with LBBB, despite the greater number of patients with false positive results who would have received inappropriate fibrinolytic treatment. Where primary percutaneous coronary intervention is practised in AMI, the benefit to risk ratio will be greater.
In conclusion, BSM is a practical and non-invasive tool for the diagnosis of AMI in the presence of LBBB. Current research suggests that BSM leads to improved sensitivity while retaining acceptable specificity compared with other 12 lead ECG methods.
Research grants: Meridian Medical Technologies Inc, Columbia, Maryland, Royal Victoria Hospital Fellowship.